---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-042798"
form_type: "8-K"
ticker: "AAPL"
cik: "0000320193"
company_name: "Apple Inc."
filed_at: "2026-11-09T21:30:40+00:00"
generated_at: "2026-11-09T21:32:14.921794+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Apple issues $7.5B of notes across seven tranches, including 5.350% 2036s and floating-rate 2028/2029s

## Summary
- Total $7.5B: $500M FRN due 2028, $750M FRN due 2029, $1.0B 4.650% 2028, $1.0B 4.750% 2029, $1.0B 4.900% 2031, $1.25B 5.100% 2033, $2.0B 5.350% 2036.
- Largest tranche is $2.0B of 5.350% notes due Nov 9, 2036; fixed-rate coupons span 4.650% to 5.350%.
- Sale closed Nov 9, 2026 under a Nov 5, 2026 underwriting agreement led by Goldman Sachs, BofA Securities, Deutsche Bank Securities and J.P. Morgan.
- Fixed-rate interest payable semi-annually May 9 and Nov 9 beginning May 9, 2027; floating-rate notes pay quarterly beginning Feb 9, 2027.
- Notes are senior unsecured obligations ranking equally with Apple's other unsecured debt, issued under a Nov 1, 2024 indenture with BNY Mellon as trustee.

## SEC filing metadata
- accession: 0001140361-26-042798
- form_type: 8-K
- ticker: AAPL
- cik: 0000320193
- company_name: Apple Inc.
- filed_at: 2026-11-09T21:30:40+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320193/000114036126042798/0001140361-26-042798-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320193/000114036126042798/ef20085077_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-042798
- JSON: https://secwatch.observer/filing/0001140361-26-042798.json
- Plain text: https://secwatch.observer/filing/0001140361-26-042798.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.